African Union Development Agency (AUDA-NEPAD) COVID19 Webinar Series on galvanising African industrial capacity to supply pharmaceuticals and medical products

Topic: Access to medicines – A national and continental security issue.

12th May 2020

3pm S.A.S.T / 1pm GMT


Assembly Decision {Assembly/AU/Dec.55(IV)} taken during the Abuja Summit in January 2005 requested the AU Commission to develop a Pharmaceutical Manufacturing Plan for Africa (PMPA) within the framework of the then NEPAD.

In 2012 the 19th African Union Assembly Decision {Assembly AU/Dec.442(XIX)} on AU endorsed the PMPA Business plan which provides a package of technical and policy solutions to the challenges hampering Africa’s progress to achieve the PMPA’s objective of creating a viable pharmaceutical industry that can provide in a sustainable manner the much needed essential medical products to improve public health outcomes while creating jobs, boosting research and development across the pharmaceutical manufacturing value chain and enhancing the industrial base of the continent.

The PMPA is premised on the inalienable principle that access to all essential medicines that are affordable, safe, efficacious, and of good quality, is a fundamental human right. It further proposes that the promotion of industrial development and the safeguarding and protection of public health are not mutually exclusive priorities and that the production of quality medicines and the development of an international GMP compliant industry in Africa are possible, desirable and eminently possible.

This right and the possibility of building the right industrial base on the continent is no longer desirable, it is fast emerging as a national and continental security issue. This becomes more critical in the wake of the Covid-19 pandemic making it urgently necessary for Africa, more than ever, to look inward for solutions to curb the negative effect of the pandemic and the dependence on aid from other continents.

The African continent depends on imports for over 80% of its medicines needs and in most sub-Saharan countries 100% of its vaccines, health technologies and medical devices. This situation is not sustainable.

It is against this background that AUDA-NEPAD is organising a series of webinars, which was launched on 13 th April 2020, and its aimed at galvanising African industrial capacity to produce the much-needed pharmaceuticals and medical supplies to respond to Covid19 and future pandemics. The focus of the third meeting will be on the importance of building local pharmaceutical capabilities as a means of contributing to medicines security in Africa.

Speakers and Panelists

Dr. Jayasree K. Iyer

Executive Director, Access to Medicine Foundation

DR Matshediso

Dr Matshidiso Moeti

Director, WHO Regional Office for Africa


Dr. John Nkengasong

Director, African Centres for Disease Control and Prevention (ACDC)


Dr. Margaret Agama-Anyetei

Head of Health, Nutrition and Population Division - Department for Social Affairs, African Union

Dr. Janet Byaruhanga,

Dr. Janet Byaruhanga

Senior Programme Officer, Public Health, AUDA-NEPAD

Bankole Eniola

Executive Director, DFS-Africa


Nazzem Mohammed

Vice Chairperson of FAPMA


AUDA-NEPAD, FAPMA and its regional TRADE associations, SAGMA, WAPMA, FEAPM, AfDB, Afrexim Bank, UNECA, USP, DFS Africa.

Speaker Presentation Link Webinar Report Questions & Answers
Dr. Jayasree K. Iyer - Executive Director, Access to Medicine Foundation
Dr. Tumusiime Prosper – WHO Regional Office for Africa